News
Google News: Biogen gets access to Isis spinal disorder therapy
[Pharma Times] - Commenting on the deal, Biogen chief executive George Scangos said SMA is "a heartbreaking disease – it can kill children before their second birthday and there are currently no therapies to treat the disease”. He added that “it is exactly the kind of
sorted by relevance / date